SCHEMBL286185

SCHEMBL286185

O=C(O)c1c(-c2ccc(Cl)cc2)noc1C=Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.48
GPBAR1 Q8TDU6 6/20 0.47
POLB P06746 1/20 0.45
NPC1 O15118 1/20 0.45
MEN1 O00255 4/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.43
CYP1B1 Q16678 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C8 P10632 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2E1 P05181 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2A6 P11509 1/20 0.42
CYP4B1 P13584 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP3A5 P20815 1/20 0.42
CYP2A7 P20853 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL286184 1.00 KMT2A (0.48) KMT2AGPBAR1POLBNPC1MEN1
SCHEMBL535778 0.90 KMT2A (0.50) KMT2APOLBMEN1MAPTMAPK1
SCHEMBL535779 0.90 KMT2A (0.50) KMT2APOLBMEN1MAPTMAPK1
SCHEMBL286375 0.87 CASP3 (0.48) KMT2AGPBAR1POLBMEN1MAPK1
SCHEMBL286376 0.87 CASP3 (0.48) KMT2AGPBAR1POLBMEN1MAPK1
SCHEMBL535875 0.84 KMT2A (0.43) KMT2ANPC1MEN1MAPTMAPK1
SCHEMBL535874 0.84 KMT2A (0.43) KMT2ANPC1MEN1MAPTMAPK1
SCHEMBL286313 0.79 KMT2A (0.48) KMT2AGPBAR1POLBNPC1MEN1
SCHEMBL286314 0.79 KMT2A (0.48) KMT2AGPBAR1POLBNPC1MEN1
SCHEMBL536326 0.76 KDM4E (0.43) NPC1MAPTMAPK1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2414354-B1 Hydroxy-methyl isoxazole derivatives as gaba a modulators HOFFMANN LA ROCHE (CH) 2012-12-12 EP disclosed
US-8222246-B2 Substituted isoxazoles HOFFMANN-LA ROCHE INC. (US) 2012-07-17 US disclosed
US-8163728-B2 Pyrazoles HOFFMANN-LA ROCHE INC. (US) 2012-04-24 US disclosed
EP-2427455-A1 ISOXAZOLE-PYRAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2012-03-14 EP disclosed
EP-2414354-A1 Hydroxy-methyl isoxazole derivatives as gaba a modulators F. Hoffmann-La Roche AG (CH) 2012-02-08 EP disclosed
WO-2010127975-A1 ISOXAZOLE-PYRAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2010-11-11 WO disclosed
US-20100286115-A1 PYRAZOLES ROCHE PALO ALTO LLC 2010-11-11 US disclosed
WO-2010112475-A1 HYDROXY-METHYL ISOXAZOLE DERIVATIVES AS GABA A MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2010-10-07 WO disclosed
US-20100256127-A1 SUBSTITUTED ISOXAZOLES ROCHE PALO ALTO LLC 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286115-A1 PYRAZOLES GABRA5, GABRA1, GABRA3 KMT2A 3379/4885GPBAR1 109/4885POLB 3953/4885
US-20100256127-A1 SUBSTITUTED ISOXAZOLES GABRA5, GABRA1, GABRA3 KMT2A 2613/4885GPBAR1 129/4885POLB 4593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.